Regional News Archives - Page 142 of 190 - Journal for Clinical Studies

Current Edition

news

Intra-Cellular’s depression drug goes 1 for 2 in Phase 3 studies

Credit: Elizabeth Regan / Industry Dive Intra-Cellular Therapies said Monday its experimental psychiatric drug had mixed results in two Phase 3 studies of patien...

11 July 2019 news | North America | Regional News

Continue Reading →

Europe

Array’s colorectal cancer data shows why Pfizer splashed out $11B for the biotech

Whether Array is worth $11 billion for Pfizer is dependent on whether both Braftovi and Mektovi are needed in colorectal cancer. (Array BioPharma) One key incent...

11 July 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Amarin plots salesforce hiring binge to prep for new Vascepa approval

Amarin will double its sales force for fish-oil derivative Vascepa on the back of a record six months of sales. (Pixabay) Amarin has been teasing big plans ...

4 July 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Gilead firms up path to market for key arthritis drug

Gilead said Tuesday it plans to submit its experimental arthritis treatment filgotinib for U.S. approval this year, a speedier-than-expected timeline that could shor...

4 July 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

New study showing drug prolongs life for patients with ovarian cancer

Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their li...

4 July 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs Wayne, PA, June...

28 June 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

FDA fast-tracks BI, Lilly’s Jardiance in chronic heart failure

Boehringer Ingelheim and Eli Lilly's Jardiance is chasing the FDA's blessing in chronic heart failure. (Boehringer Ingelheim) When Boehringer Ingelheim and Eli L...

27 June 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Minerva’s sleep drug bests Ambien, placebo in dose-finding study

Minerva Neurosciences is developing seltorexant with Janssen as an add-on treatment for major depressive disorder and insomnia disorder. (alex-mit/iStock/Getty Imag...

27 June 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Beating Keytruda a big task, Exelixis and Roche find

A combination of Cotellic and Tecentriq failed to beat Keytruda monotherapy in newly diagnosed patients with non-mutated melanoma in a Phase 3 trial, according to an...

27 June 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Regeneron, Sanofi antibody works in asthma, but not as well as Dupixent

Regeneron and Sanofi said Friday their experimental IL-33 antibody improved asthma control better than placebo in a Phase 2 study.But REGN3500 didn't beat the two dr...

27 June 2019 Europe | news | North America | Regional News

Continue Reading →